We provide you with 20 years of free, institutional-grade data for ORGO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ORGO. Explore the full financial landscape of ORGO stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2023-11-09 | 1661181 | ORGO | 10-Q | Url |
| 2023-08-09 | 1661181 | ORGO | 10-Q | Url |
| 2023-05-10 | 1661181 | ORGO | 10-Q | Url |
| 2023-03-01 | 1661181 | ORGO | 10-K | Url |
| 2022-11-09 | 1661181 | ORGO | 10-Q | Url |
| 2022-08-09 | 1661181 | ORGO | 10-Q | Url |
| 2022-05-10 | 1661181 | ORGO | 10-Q | Url |
| 2022-03-01 | 1661181 | ORGO | 10-K | Url |
| 2021-11-09 | 1661181 | ORGO | 10-Q | Url |
| 2021-08-09 | 1661181 | ORGO | 10-Q | Url |
| 2021-05-11 | 1661181 | ORGO | 10-Q | Url |
| 2021-03-16 | 1661181 | ORGO | 10-K | Url |
| 2020-11-09 | 1661181 | ORGO | 10-Q | Url |
| 2020-10-16 | 1661181 | ORGO | S-1 | Url |
| 2020-08-10 | 1661181 | ORGO | 10-Q | Url |
| 2020-05-11 | 1661181 | ORGO | 10-Q | Url |
| 2020-03-09 | 1661181 | ORGO | 10-K | Url |
| 2019-11-12 | 1661181 | ORGO | 10-Q | Url |
| 2019-08-09 | 1661181 | ORGO | 10-Q | Url |
| 2019-05-10 | 1661181 | ORGO | 10-Q | Url |
| 2019-03-18 | 1661181 | ORGO | 10-K | Url |
| 2018-11-09 | 1661181 | ORGO | 10-Q | Url |
| 2018-08-07 | 1661181 | ORGO | 10-Q | Url |
| 2018-05-10 | 1661181 | ORGO | 10-Q | Url |
| 2018-03-14 | 1661181 | ORGO | 10-K | Url |
| 2017-11-14 | 1661181 | ORGO | 10-Q | Url |
| 2017-08-11 | 1661181 | ORGO | 10-Q | Url |
| 2017-05-12 | 1661181 | ORGO | 10-Q | Url |
| 2017-03-28 | 1661181 | ORGO | 10-K | Url |
| 2016-11-18 | 1661181 | ORGO | 10-Q | Url |
| 2016-09-02 | 1661181 | ORGO | S-1 | Url |
Organogenesis Holdings Inc(NASDAQ:ORGO) 
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound cove...
Website: http://organogenesis.com
Founded: 1985
Full Time Employees: 835
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about ORGO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.